Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000261436

Medchemexpress LLC Zl0590 | 2230496-99-6 | MFCD34604141 | 99.9% | C23H27F3N4O4S | 10MG
SDP

Catalog No. 5000261436
Encompass_Preferred

ZL0590 is a potent, orally active BRD4 BD1-selective inhibitor (IC50 = 90 nM) used for research into BRD4-mediated biology and inflammatory disease models. It has demonstrated anti-inflammatory effects in animal models and is provided in both solid form and as a DMSO solution, with high reported purity for research use.

  • Potent BRD4 BD1 inhibition with low-nanomolar activity.
  • Demonstrated anti-inflammatory activity in animal models.
  • Suitable for in vitro and in vivo research applications.
  • Available as solid and 10 mM solution in DMSO for flexibility.
  • High reported purity for research-grade experiments.

Catalog No. 50-002-61436 Supplier Medchemexpress LLC Supplier No. HY14531010MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ZL0590 is a potent, orally active BRD4 BD1-selective inhibitor (IC50 = 90 nM) used for research into BRD4-mediated biology and inflammatory disease models. It has demonstrated anti-inflammatory effects in animal models and is provided in both solid form and as a DMSO solution, with high reported purity for research use.

  • Potent BRD4 BD1 inhibition with low-nanomolar activity.
  • Demonstrated anti-inflammatory activity in animal models.
  • Suitable for in vitro and in vivo research applications.
  • Available as solid and 10 mM solution in DMSO for flexibility.
  • High reported purity for research-grade experiments.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.